John Jumper

John Michael Jumper is an American chemist and computer scientist, born January 1, 1985 in Little Rock, Arkansas. He is a director and the research lead for AlphaFold at Google DeepMind, the protein-structure-prediction program that produced AlphaFold 2 in 2020 and AlphaFold 3 in 2024. As of May 2026, he holds a one-quarter share of the 2024 Nobel Prize in Chemistry alongside Demis Hassabis and David Baker, is a Fellow of the Royal Society, and continues to lead the AlphaFold research program at Google DeepMind in London.

At a glance

• Education: BS in physics and mathematics, Vanderbilt University (2007); MPhil in theoretical condensed matter physics, St Edmund's College, University of Cambridge (2010), as a Marshall Scholar; MS (2012) and PhD (2017) in theoretical chemistry, University of Chicago, supervised by Tobin Sosnick and Karl Freed.
• Current role: Director and research lead, AlphaFold, at Google DeepMind, since 2017.
• Key contributions: First author of AlphaFold 2 (Nature, July 2021), co-author of AlphaFold 3 (Nature, May 2024), and senior contributor to the AlphaFold Protein Structure Database released jointly with EMBL-EBI.
• Awards: 2024 Nobel Prize in Chemistry (one-quarter share); Albert Lasker Basic Medical Research Award (2023); Breakthrough Prize in Life Sciences (2023); Canada Gairdner International Award (2023); Wiley Prize in Biomedical Sciences (2022); BBVA Foundation Frontiers of Knowledge Award (2022); Fellow of the Royal Society (2025); elected to the National Academy of Engineering (2026).
• Wikipedia: John M. Jumper
• Google Scholar: John Jumper
• Google DeepMind bio: deepmind.google/about

Origins

Jumper was born on January 1, 1985 in Little Rock, Arkansas, and grew up there before going on to undergraduate study in physics and mathematics at Vanderbilt University, graduating in 2007. He won a Marshall Scholarship in his final undergraduate year and used it to read theoretical condensed matter physics at St Edmund's College, University of Cambridge, completing the Master of Philosophy degree in 2010.

After Cambridge, Jumper returned to the United States and joined D. E. Shaw Research in New York, the computational-biology arm of the Shaw hedge-fund group, as a research scientist working on molecular-dynamics simulations of proteins. He spent approximately three years at the firm and developed the methodological interest in protein folding and dynamics that would carry through the rest of his career.

In 2011 Jumper enrolled at the University of Chicago for a graduate degree in theoretical chemistry, taking the Master of Science in 2012 and the Doctor of Philosophy in 2017. The doctoral work was supervised jointly by Tobin Sosnick and Karl Freed and produced a thesis titled New Methods Using Rigorous Machine Learning for Coarse-Grained Protein Folding and Dynamics. The Chicago training combined statistical physics with machine-learning methods for coarse-grained simulation, and was the technical foundation for the AlphaFold work.

Career

Jumper joined Google DeepMind in 2017 as a research scientist on the protein-structure-prediction program, immediately following the doctorate at Chicago. The team's first system, AlphaFold 1, had entered the Critical Assessment of protein Structure Prediction (CASP13) competition in 2018 and won the free-modelling category. Jumper became the technical lead for the successor effort that would become AlphaFold 2.

The CASP14 competition in November and December 2020 was the public inflection point. AlphaFold 2 entered as the DeepMind submission and produced predictions at a median Global Distance Test score of 92.4 out of 100 across the assessed targets, a level the CASP organisers and structural-biology community treated as comparable with experimentally determined structures. The result was widely reported as essentially solving the long-standing protein-folding problem for single-chain structures, and the system made the most accurate prediction for 88 of the 97 CASP14 targets.

The accompanying Nature paper, "Highly accurate protein structure prediction with AlphaFold," was published on July 15, 2021 with Jumper as first author and Demis Hassabis as a corresponding author. The release was paired with an open-source code release and a companion Nature paper covering predictions for the entire human proteome. On July 22, 2021 DeepMind launched the AlphaFold Protein Structure Database, a joint project with the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI). The database has expanded to cover predicted structures for over 200 million proteins by 2024 and is the central reference resource for the structural-biology community.

AlphaFold 3, published in Nature on May 8, 2024, extended the system from single-chain protein structures to a single diffusion-based architecture predicting protein-ligand, protein-DNA, protein-RNA, modified-residue, and protein-protein-complex structures. The work was a joint product of Google DeepMind and Isomorphic Labs, the Alphabet drug-discovery subsidiary spun out of DeepMind in November 2021. Jumper is among the senior contributors on the AlphaFold 3 paper and continues as research lead for the AlphaFold program at DeepMind. He has held a director title at Google DeepMind since approximately 2023.

The 2024 Nobel Prize in Chemistry was announced by the Royal Swedish Academy of Sciences on October 9, 2024. The prize was divided one half to David Baker of the University of Washington for computational protein design, and one half jointly to Demis Hassabis and John Jumper for protein structure prediction. Jumper, at age 39, was the second-youngest Nobel Laureate in Chemistry of the modern era. He delivered his Nobel Lecture, titled "Building chemical and biological intuition into protein structure prediction," at Aula Magna, Stockholm University, on December 8, 2024. Jumper was elected a Fellow of the Royal Society in 2025 and elected to the United States National Academy of Engineering in 2026.

Affiliations

• D. E. Shaw Research: Research scientist, approximately 2008 to 2011.
• University of Chicago: PhD candidate in theoretical chemistry, 2011 to 2017 (advised by Tobin Sosnick and Karl Freed).
• Google DeepMind: Research scientist from 2017; technical lead and senior research scientist on AlphaFold; Director and research lead, AlphaFold, to present.

Notable contributions

Jumper's published record is concentrated in the AlphaFold program at Google DeepMind, where he has been the technical lead across the AlphaFold 2 and AlphaFold 3 generations.

• AlphaFold 2 (December 2020 demonstration; Nature publication July 15, 2021). First author on the principal Nature paper "Highly accurate protein structure prediction with AlphaFold." AlphaFold 2 won the CASP14 competition at a median Global Distance Test score of 92.4 out of 100, treated by the structural-biology community as approaching experimental accuracy for single-chain structures. The result is widely cited as the moment at which deep learning crossed into mainstream computational biology.
• AlphaFold Protein Structure Database (July 22, 2021 launch). The joint Google DeepMind and European Bioinformatics Institute database of predicted protein structures, covering nearly all known proteins in UniProt. The expanded database covered over 200 million predicted structures by 2024, making it the standard reference resource for structural biology.
• AlphaFold 3 (Nature, May 8, 2024). Senior author on the joint Google DeepMind and Isomorphic Labs paper extending AlphaFold to protein-ligand, protein-DNA, protein-RNA, modified-residue, and protein-protein-complex interactions on a single diffusion-based architecture. The system shifts the AlphaFold line from protein-structure prediction toward general-purpose biomolecular interaction modelling.
• AlphaMissense (2023). Senior author on the AlphaFold-derived system for predicting the pathogenicity of human missense variants, published in Science.
• 2024 Nobel Prize in Chemistry (announced October 9, 2024). One-quarter share, jointly with Demis Hassabis, for protein structure prediction. The other half of the prize was awarded to David Baker for computational protein design. Jumper's Nobel Lecture, "Building chemical and biological intuition into protein structure prediction," was delivered at Stockholm University on December 8, 2024.
• Pre-Nobel awards. Wiley Prize in Biomedical Sciences (2022); BBVA Foundation Frontiers of Knowledge Award (2022); Breakthrough Prize in Life Sciences (2023, jointly with Hassabis); Canada Gairdner International Award (2023); Albert Lasker Basic Medical Research Award (2023, jointly with Hassabis). The Lasker citation in particular is widely treated within the biomedical-research community as a strong predictor of subsequent Nobel awards.
• Fellowships. Fellow of the Royal Society (2025); elected to the United States National Academy of Engineering (2026); included in TIME 100 Most Influential People (2024); listed in Nature's Ten people who shaped science (2021).

Investments and boards

No public personal angel-investor activity on record in AI, semiconductors, datacenters, software, or energy as of May 2026. Jumper's footprint in this section is concentrated in his ongoing operating role as research lead on AlphaFold at Google DeepMind, alongside the academic and learned-society memberships covered in the awards section.

Network

Jumper's strongest professional partnership is with Demis Hassabis, the Google DeepMind chief executive, his Nobel co-laureate on the protein-structure-prediction half of the 2024 prize, and his joint co-recipient of the 2023 Lasker, Gairdner, and Breakthrough Prize awards. The Hassabis-Jumper pairing is the most-cited collaborative authorship line on AlphaFold 2 and AlphaFold 3.

His third Nobel co-laureate is David Baker at the University of Washington, recipient of the other half of the 2024 prize for computational protein design. The Baker and Jumper laboratories are the two principal scientific anchors of the modern AI-and-protein research community, and Jumper has cited Baker's RoseTTAFold work as a parallel reference point in public lectures.

His doctoral advisors at the University of Chicago were Tobin Sosnick and Karl Freed; Jumper has cited the Sosnick laboratory's experimental work on protein folding and the Freed group's statistical-physics tradition as the academic foundations of the AlphaFold work.

His DeepMind co-authors across the AlphaFold 2 and AlphaFold 3 papers include Richard Evans, Alexander Pritzel, Tim Green, Olaf Ronneberger, Kathryn Tunyasuvunakool, Russ Bates, Augustin Žídek, and Anna Potapenko, the recurring senior contributors on the principal Nature publications. The DeepMind protein-modelling team coordinates closely with Isomorphic Labs on AlphaFold 3 and subsequent biomolecular-interaction research. Jumper's wife, Carolyn, has been described in his Nobel-related interviews as a sustained source of professional support across the AlphaFold period.

Position in the field

As of May 2026, Jumper is the most-cited single technical lead on a deep-learning system to win a Nobel Prize. His direct comparators on the structural-biology side are David Baker at the University of Washington and the broader academic protein-design community; on the industrial-AI side they are senior research leads at Frontier laboratories whose work has produced widely-cited foundational artifacts but not Nobel-class scientific recognition.

The protein-folding problem on which AlphaFold 2 produced the inflection result had stood as the central open question in computational biology for fifty years before the December 2020 CASP14 result. The shift from that long-running open problem to a settled benchmark within a single competition cycle, and the subsequent release of the AlphaFold Protein Structure Database at scale, are the two most-cited public facts in coverage of the program, characterized by the Royal Swedish Academy of Sciences in its Nobel Prize press release as the principal industrial-AI scientific result to date.

Among the senior researchers in Google DeepMind's London operation, Jumper is the principal scientific anchor for the AlphaFold and biomolecular-modelling line, sitting alongside Demis Hassabis on the executive side and operating in close coordination with Isomorphic Labs on the drug-discovery applications. The 2025 Royal Society Fellowship and the 2026 National Academy of Engineering election reinforced the academic-credential stack that runs alongside the industrial role.

Outlook

Open questions over the next 6 to 18 months:

• Successor work after AlphaFold 3. Whether the next iteration of the AlphaFold line targets dynamic biomolecular ensembles, intrinsically disordered proteins, or large-scale cellular interaction modelling, and how the public-release cadence compares with AlphaFold 2 and 3.
• Coordination with Isomorphic Labs. The depth of operational overlap between the AlphaFold research program at Google DeepMind and the Isomorphic Labs drug-discovery pipeline, particularly as Isomorphic moves into first-in-human clinical trials.
• Expansion of the AlphaFold Database. Whether the EBI-hosted database expands beyond UniProt protein structures into protein-protein-complex, protein-ligand, or protein-RNA structures generated by AlphaFold 3.
• Public commentary cadence. Whether Jumper continues the post-Nobel speaking pattern of multiple keynote addresses per year, or returns to the pre-Nobel research-focused profile of limited public commentary.
• AlphaFold-derived models in adjacent domains. Whether the AlphaFold methodological line generates further specialized models in adjacent biomedical-research domains beyond AlphaMissense.
• Long-term role at Google DeepMind. Whether Jumper continues at Google DeepMind through the next research cycle, given the broader 2025 to 2026 pattern of senior researchers leaving frontier labs to found independent ventures.

Sources

• John M. Jumper. Wikipedia biographical entry; covers education, the AlphaFold program, the 2024 Nobel Prize, and major awards.
• John M. Jumper. Encyclopaedia Britannica biographical entry; concise reference for the D. E. Shaw Research period and the DeepMind career.
• John Jumper – Facts. NobelPrize.org official facts page on the 2024 prize, including the prize-share fraction and the institutional affiliation.
• Press release: The Nobel Prize in Chemistry 2024. Royal Swedish Academy of Sciences press release on the joint award to Hassabis, Jumper, and Baker.
• Highly accurate protein structure prediction with AlphaFold. The July 15, 2021 AlphaFold 2 Nature paper, with Jumper as first author and Hassabis as corresponding author.
• Accurate structure prediction of biomolecular interactions with AlphaFold 3. The May 8, 2024 AlphaFold 3 Nature paper, jointly authored by Google DeepMind and Isomorphic Labs.
• AlphaFold Protein Structure Database. The joint Google DeepMind and EMBL-EBI public database of predicted protein structures.
• AlphaFold technology page. Google DeepMind's program page for the AlphaFold line.
• UChicago alum John Jumper shares Nobel Prize for model to predict protein structures. University of Chicago institutional coverage of the October 2024 Nobel announcement.
• AlphaFold developers Demis Hassabis and John Jumper share the 2023 Albert Lasker Basic Medical Research Award. Journal of Clinical Investigation citation for the 2023 Lasker award.
• Nobel Prize lecture: John Jumper, Nobel Prize in Chemistry 2024. NobelPrize.org page for the December 8, 2024 lecture "Building chemical and biological intuition into protein structure prediction."
• Photo: John Jumper, 2024 Nobel Prize Laureate in Chemistry, CC BY-SA 4.0 Arthur Petron / WikiPortraits.